Skip to main content
AAN.com
Articles
November 24, 2008

Determinants of the distribution and severity of hypoperfusion in patients with ischemic stroke

November 25, 2008 issue
71 (22) 1804-1811

Abstract

Background: In acute cerebral ischemia, two variables characterize the extent of hypoperfusion: the volume of hypoperfused tissue and the intensity of hypoperfusion within these regions. We evaluated the determinants of the intensity of hypoperfusion within oligemic regions among patients who were eligible for recanalization therapy for acute ischemic stroke.
Methods: We analyzed data, including pretreatment diffusion-weighted imaging (DWI) and perfusion-weighted imaging, on 119 patients with acute middle cerebral artery infarctions. The intensity of hypoperfusion within oligemic regions was characterized by the hypoperfusion intensity ratio (HIR), defined as the volume of tissue with severe hypoperfusion (Tmax ≥8 seconds) divided by the volume of tissue with any hypoperfusion (Tmax ≥2 seconds). Based on the DWI data, we divided the patients into four stroke phenotypes: large cortical, small (<1 cm diameter) cortical, border-zone, and deep pattern.
Results: The mean (SD) volume of severe hypoperfusion was 54.6 (52.5) mL, and that of any hypoperfusion was 140.8 (81.3) mL. The HIR ranged widely, from 0.002 to 0.974, with a median of 0.35 (interquartile range 0.13–0.60). The volume of any hypoperfusion did not predict the intensity of hypoperfusion within the affected region (r = 0.10, p = 0.284). Angiographic collateral flow grade was associated with HIRs (p value for trend = 0.019) and differed among DWI lesion patterns. In multivariate analysis, diastolic pressure on admission (odds ratio 0.959, 95% CI 0.922–0.998) and DWI pattern of deep infarcts (odds ratio 18.004 compared with large cortical pattern, 95% CI 1.855–173.807) were independently associated with a low HIR.
Conclusions: The intensity of hypoperfusion within an oligemic field is largely independent of the size of the oligemia region. Predictors of lesser intensity of hypoperfusion are lower diastolic blood pressure and presence of a deep diffusion-weighted imaging lesion pattern.
GLOSSARY: AIF = arterial input function; DWI = diffusion-weighted imaging; HDL = high-density lipoprotein; HIR = hypoperfusion intensity ratio; ICA = internal carotid artery; IQR = interquartile range; LDL = low-density lipoprotein; MCA = middle cerebral artery; MR = magnetic resonance; MRA = magnetic resonance angiography; NIHSS = NIH Stroke Scale; OR = odds ratio; PWI = perfusion-weighted imaging.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (figure_e-1.tif)

REFERENCES

1.
Astrup J, Symon L, Branston NM, Lassen NA. Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia. Stroke 1977;8:51–57.
2.
Donnan GA, Davis SM. Neuroimaging, the ischaemic penumbra, and selection of patients for acute stroke therapy. Lancet Neurol 2002;1:417–425.
3.
Furlan AJ, Eyding D, Albers GW, et al. Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006;37:1227–1231.
4.
Hacke W, Albers G, Al-Rawi Y, et al. The desmoteplase in acute ischemic stroke trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66–73.
5.
Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60:508–517.
6.
Kohrmann M, Juttler E, Fiebach JB, et al. MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol 2006;5:661–667.
7.
Ribo M, Molina CA, Rovira A, et al. Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol. Stroke 2005;36:602–606.
8.
Hjort N, Butcher K, Davis SM, et al. Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke 2005;36:388–397.
9.
Davis SM, Donnan GA, Butcher KS, Parsons M. Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging. Curr Opin Neurol 2005;18:47–52.
10.
Butcher KS, Parsons M, MacGregor L, et al. Refining the perfusion-diffusion mismatch hypothesis. Stroke 2005;36:1153–1159.
11.
Kidwell CS, Alger JR, Saver JL. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 2003;34:2729–2735.
12.
Shih LC, Saver JL, Alger JR, et al. Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke 2003;34:1425–1430.
13.
Lee LJ, Kidwell CS, Alger J, Starkman S, Saver JL. Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography. Stroke 2000;31:1081–1089.
14.
Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages, part I: mathematical approach and statistical analysis. Magn Reson Med 1996;36:715–725.
15.
Smaha LA. The American Heart Association Get with the Guidelines program. Am Heart J 2004;148:S46–S48.
16.
Higashida RT, Furlan AJ, Roberts H, et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:e109–e137.
17.
Heinsius T, Bogousslavsky J, Van Melle G. Large infarcts in the middle cerebral artery territory: etiology and outcome patterns. Neurology 1998;50:341–350.
18.
Kimura K, Minematsu K, Koga M, et al. Microembolic signals and diffusion-weighted MR imaging abnormalities in acute ischemic stroke. AJNR Am J Neuroradiol 2001;22:1037–1042.
19.
Yong SW, Bang OY, Lee PH, Li WY. Internal and cortical border-zone infarction: clinical and diffusion-weighted imaging features. Stroke 2006;37:841–846.
20.
Baird AE, Lovblad KO, Schlaug G, Edelman RR, Warach S. Multiple acute stroke syndrome: marker of embolic disease? Neurology 2000;54:674–678.
21.
Caplan LR. Brain embolism, revisited. Neurology 1993;43:1281–1287.
22.
Masuda J, Yutani C, Ogata J, Kuriyama Y, Yamaguchi T. Atheromatous embolism in the brain: a clinicopathologic analysis of 15 autopsy cases. Neurology 1994;44:1231–1237.
23.
Bang OY, Lee PH, Heo KG, Joo US, Yoon SR, Kim SY. Specific DWI lesion patterns predict prognosis after acute ischaemic stroke within the MCA territory. J Neurol Neurosurg Psychiatry 2005;76:1222–1228.
24.
Kim JJ, Fischbein NJ, Lu Y, Pham D, Dillon WP. Regional angiographic grading system for collateral flow: correlation with cerebral infarction in patients with middle cerebral artery occlusion. Stroke 2004;35:1340–1344.
25.
Christoforidis GA, Mohammad Y, Kehagias D, Avutu B, Slivka AP. Angiographic assessment of pial collaterals as a prognostic indicator following intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2005;26:1789–1797.
26.
Bang OY, Saver JL, Buck BH, et al. Impact of collateral flow on tissue fate in acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2008;79:625–629.
27.
Tsivgoulis G, Saqqur M, Sharma VK, Lao AY, Hill MD, Alexandrov AV. Association of pretreatment blood pressure with tissue plasminogen activator-induced arterial recanalization in acute ischemic stroke. Stroke 2007;38:961–966.
28.
Stead LG, Gilmore RM, Decker WW, Weaver AL, Brown RD Jr. Initial emergency department blood pressure as predictor of survival after acute ischemic stroke. Neurology 2005;65:1179–1183.
29.
Mattle HP, Kappeler L, Arnold M, et al. Blood pressure and vessel recanalization in the first hours after ischemic stroke. Stroke 2005;36:264–268.

Information & Authors

Information

Published In

Neurology®
Volume 71Number 22November 25, 2008
Pages: 1804-1811
PubMed: 19029520

Publication History

Published online: November 24, 2008
Published in print: November 25, 2008

Permissions

Request permissions for this article.

Notes

Authors

Affiliations & Disclosures

O. Y. Bang, MD, PhD
From the Department of Neurology (O.Y.B.), Samsung Medical Center, Sungkyunkwan University, South Korea; and Departments of Neurology (O.Y.B., J.L.S., J.R.A., B.O., D.S.L.) and Emergency Medicine (S.S.), University of California, Los Angeles, CA.
J. L. Saver, MD
From the Department of Neurology (O.Y.B.), Samsung Medical Center, Sungkyunkwan University, South Korea; and Departments of Neurology (O.Y.B., J.L.S., J.R.A., B.O., D.S.L.) and Emergency Medicine (S.S.), University of California, Los Angeles, CA.
J. R. Alger, PhD
From the Department of Neurology (O.Y.B.), Samsung Medical Center, Sungkyunkwan University, South Korea; and Departments of Neurology (O.Y.B., J.L.S., J.R.A., B.O., D.S.L.) and Emergency Medicine (S.S.), University of California, Los Angeles, CA.
S. Starkman, MD
From the Department of Neurology (O.Y.B.), Samsung Medical Center, Sungkyunkwan University, South Korea; and Departments of Neurology (O.Y.B., J.L.S., J.R.A., B.O., D.S.L.) and Emergency Medicine (S.S.), University of California, Los Angeles, CA.
B. Ovbiagele, MD
From the Department of Neurology (O.Y.B.), Samsung Medical Center, Sungkyunkwan University, South Korea; and Departments of Neurology (O.Y.B., J.L.S., J.R.A., B.O., D.S.L.) and Emergency Medicine (S.S.), University of California, Los Angeles, CA.
D. S. Liebeskind, MD
From the Department of Neurology (O.Y.B.), Samsung Medical Center, Sungkyunkwan University, South Korea; and Departments of Neurology (O.Y.B., J.L.S., J.R.A., B.O., D.S.L.) and Emergency Medicine (S.S.), University of California, Los Angeles, CA.
For the UCLA Collateral Investigators
From the Department of Neurology (O.Y.B.), Samsung Medical Center, Sungkyunkwan University, South Korea; and Departments of Neurology (O.Y.B., J.L.S., J.R.A., B.O., D.S.L.) and Emergency Medicine (S.S.), University of California, Los Angeles, CA.

Notes

Address correspondence and reprint requests to Dr. Oh Young Bang, Department of Neurology and Stroke Center, Samsung Medical Center, Sungkyunkwan University, 50 Irwon-dong, Gangnam-gu, Seoul, 135-710, South Korea [email protected]

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Arterial hypotension “magnitude” and neurological outcome during mechanical thrombectomy under general anesthesia, Journal of Stroke and Cerebrovascular Diseases, 33, 11, (107838), (2024).https://doi.org/10.1016/j.jstrokecerebrovasdis.2024.107838
    Crossref
  2. Collateral Circulation and BNP in Predicting Outcome of Acute Ischemic Stroke Patients with Atherosclerotic versus Cardioembolic Cerebral Large-Vessel Occlusion Who Underwent Endovascular Treatment, Brain Sciences, 13, 4, (539), (2023).https://doi.org/10.3390/brainsci13040539
    Crossref
  3. Case report: Flow changes in routes of collateral circulation in patients with LVO and low NIHSS: a point favor to treat, Frontiers in Neurology, 14, (2023).https://doi.org/10.3389/fneur.2023.1165484
    Crossref
  4. Hypoperfusion Intensity Ratio Correlates with Angiographic Collaterals and Infarct Growth in Acute Stroke with Thrombectomy, Current Medical Imaging Formerly Current Medical Imaging Reviews, 19, 13, (2023).https://doi.org/10.2174/1573405619666230123142657
    Crossref
  5. Effect of arteriosclerotic intracranial arterial vessel wall enhancement on downstream collateral flow, Chinese Medical Journal, (2023).https://doi.org/10.1097/CM9.0000000000002307
    Crossref
  6. Implications of Post-recanalization Perfusion Deficit After Acute Ischemic Stroke: a Scoping Review of Clinical and Preclinical Imaging Studies, Translational Stroke Research, 15, 1, (179-194), (2023).https://doi.org/10.1007/s12975-022-01120-6
    Crossref
  7. Prognostic Accuracy of CTP Summary Maps in Patients with Large Vessel Occlusive Stroke and Poor Revascularization after Mechanical Thrombectomy—Comparison of Three Automated Perfusion Software Applications, Tomography, 8, 3, (1350-1362), (2022).https://doi.org/10.3390/tomography8030109
    Crossref
  8. Leukoaraiosis Distribution and Cerebral Collaterals: A Systematic Review and Meta-Analysis, Frontiers in Neurology, 13, (2022).https://doi.org/10.3389/fneur.2022.869329
    Crossref
  9. Pre-stroke Physical Activity and Cerebral Collateral Circulation in Ischemic Stroke: A Potential Therapeutic Relationship?, Frontiers in Neurology, 13, (2022).https://doi.org/10.3389/fneur.2022.804187
    Crossref
  10. Correlation of Collateral Scores Derived from Whole-Brain Time-Resolved Flat Panel Detector Imaging in Acute Ischemic Stroke, American Journal of Neuroradiology, (2022).https://doi.org/10.3174/ajnr.A7657
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share